id	sid	tid	token	lemma	pos
dpc-2094	1	1	dermatology	dermatology	NOUN
dpc-2094	1	2	:	:	PUNCT
dpc-2094	1	3	practical	practical	ADJ
dpc-2094	1	4	and	and	CCONJ
dpc-2094	1	5	conceptual	conceptual	ADJ
dpc-2094	1	6	research	research	NOUN
dpc-2094	1	7	letter	letter	NOUN
dpc-2094	2	1	|	|	ADV
dpc-2094	2	2	dermatol	dermatol	ADJ
dpc-2094	2	3	pract	pract	NOUN
dpc-2094	2	4	concept	concept	NOUN
dpc-2094	2	5	.	.	PUNCT
dpc-2094	3	1	2022;12(4):e2022169	2022;12(4):e2022169	NUM
dpc-2094	3	2	1	1	NUM
dpc-2094	3	3	primary	primary	ADJ
dpc-2094	3	4	cutaneous	cutaneous	ADJ
dpc-2094	3	5	follicle	follicle	NOUN
dpc-2094	3	6	center	center	NOUN
dpc-2094	3	7	b	b	NOUN
dpc-2094	3	8	-	-	PUNCT
dpc-2094	3	9	cell	cell	NOUN
dpc-2094	3	10	lymphoma	lymphoma	NOUN
dpc-2094	3	11	at	at	ADP
dpc-2094	3	12	the	the	DET
dpc-2094	3	13	site	site	NOUN
dpc-2094	3	14	of	of	ADP
dpc-2094	3	15	a	a	DET
dpc-2094	3	16	resolved	resolve	VERB
dpc-2094	3	17	herpes	herpe	NOUN
dpc-2094	3	18	zoster	zoster	PROPN
dpc-2094	3	19	eruption	eruption	PROPN
dpc-2094	3	20	francesco	francesco	PROPN
dpc-2094	3	21	messina1	messina1	PROPN
dpc-2094	3	22	,	,	PUNCT
dpc-2094	3	23	giulia	giulia	PROPN
dpc-2094	3	24	tadiotto	tadiotto	PROPN
dpc-2094	3	25	cicogna1	cicogna1	PROPN
dpc-2094	3	26	,	,	PUNCT
dpc-2094	3	27	roberto	roberto	PROPN
dpc-2094	3	28	salmaso1	salmaso1	PROPN
dpc-2094	3	29	,	,	PUNCT
dpc-2094	3	30	riccardo	riccardo	PROPN
dpc-2094	3	31	rondinone1	rondinone1	PROPN
dpc-2094	3	32	,	,	PUNCT
dpc-2094	3	33	mauro	mauro	PROPN
dpc-2094	3	34	alaibac1	alaibac1	NOUN
dpc-2094	3	35	1	1	NUM
dpc-2094	3	36	dermatology	dermatology	NOUN
dpc-2094	3	37	unit	unit	NOUN
dpc-2094	3	38	,	,	PUNCT
dpc-2094	3	39	department	department	NOUN
dpc-2094	3	40	of	of	ADP
dpc-2094	3	41	medicine	medicine	NOUN
dpc-2094	3	42	,	,	PUNCT
dpc-2094	3	43	university	university	PROPN
dpc-2094	3	44	of	of	ADP
dpc-2094	3	45	padua	padua	PROPN
dpc-2094	3	46	,	,	PUNCT
dpc-2094	3	47	padua	padua	PROPN
dpc-2094	3	48	,	,	PUNCT
dpc-2094	3	49	italy	italy	PROPN
dpc-2094	3	50	key	key	ADJ
dpc-2094	3	51	words	word	NOUN
dpc-2094	3	52	:	:	PUNCT
dpc-2094	3	53	herpes	herpe	NOUN
dpc-2094	3	54	zoster	zoster	NOUN
dpc-2094	3	55	,	,	PUNCT
dpc-2094	3	56	lymphoma	lymphoma	NOUN
dpc-2094	3	57	,	,	PUNCT
dpc-2094	3	58	clobetasol	clobetasol	NOUN
dpc-2094	3	59	,	,	PUNCT
dpc-2094	3	60	wolf	wolf	PROPN
dpc-2094	3	61	response	response	NOUN
dpc-2094	3	62	citation	citation	NOUN
dpc-2094	3	63	:	:	PUNCT
dpc-2094	3	64	messina	messina	PROPN
dpc-2094	3	65	f	f	PROPN
dpc-2094	3	66	,	,	PUNCT
dpc-2094	3	67	tadiotto	tadiotto	NOUN
dpc-2094	3	68	cicogna	cicogna	ADV
dpc-2094	3	69	g	g	PROPN
dpc-2094	3	70	,	,	PUNCT
dpc-2094	3	71	salmaso	salmaso	PROPN
dpc-2094	3	72	r	r	NOUN
dpc-2094	3	73	,	,	PUNCT
dpc-2094	3	74	rondinone	rondinone	NOUN
dpc-2094	3	75	r	r	NOUN
dpc-2094	3	76	,	,	PUNCT
dpc-2094	3	77	alaibac	alaibac	PROPN
dpc-2094	3	78	m.	m.	NOUN
dpc-2094	3	79	primary	primary	ADJ
dpc-2094	3	80	cutaneous	cutaneous	ADJ
dpc-2094	3	81	follicle	follicle	NOUN
dpc-2094	3	82	center	center	NOUN
dpc-2094	3	83	b	b	NOUN
dpc-2094	3	84	lymphoma	lymphoma	NOUN
dpc-2094	3	85	at	at	ADP
dpc-2094	3	86	the	the	DET
dpc-2094	3	87	site	site	NOUN
dpc-2094	3	88	of	of	ADP
dpc-2094	3	89	a	a	DET
dpc-2094	3	90	resolved	resolve	VERB
dpc-2094	3	91	herpes	herpe	NOUN
dpc-2094	3	92	zoster	zoster	NOUN
dpc-2094	3	93	eruption	eruption	NOUN
dpc-2094	3	94	.	.	PUNCT
dpc-2094	4	1	dermatol	dermatol	NOUN
dpc-2094	4	2	pract	pract	PROPN
dpc-2094	4	3	concept	concept	NOUN
dpc-2094	4	4	.	.	PUNCT
dpc-2094	5	1	2022;12(4):e2022169	2022;12(4):e2022169	X
dpc-2094	5	2	.	.	PUNCT
dpc-2094	5	3	doi	doi	PROPN
dpc-2094	5	4	:	:	PUNCT
dpc-2094	5	5	https://doi.org/10.5826/dpc.1204a169	https://doi.org/10.5826/dpc.1204a169	PROPN
dpc-2094	5	6	accepted	accept	VERB
dpc-2094	5	7	:	:	PUNCT
dpc-2094	5	8	march	march	PROPN
dpc-2094	5	9	3	3	NUM
dpc-2094	5	10	,	,	PUNCT
dpc-2094	5	11	2022	2022	NUM
dpc-2094	5	12	;	;	PUNCT
dpc-2094	5	13	published	publish	VERB
dpc-2094	5	14	:	:	PUNCT
dpc-2094	5	15	october	october	PROPN
dpc-2094	5	16	2022	2022	NUM
dpc-2094	6	1	copyright	copyright	NOUN
dpc-2094	6	2	:	:	PUNCT
dpc-2094	6	3	©	©	PROPN
dpc-2094	6	4	2022	2022	NUM
dpc-2094	6	5	messina	messina	PROPN
dpc-2094	6	6	et	et	PROPN
dpc-2094	6	7	al	al	PROPN
dpc-2094	6	8	.	.	PUNCT
dpc-2094	7	1	this	this	PRON
dpc-2094	7	2	is	be	AUX
dpc-2094	7	3	an	an	DET
dpc-2094	7	4	open	open	ADJ
dpc-2094	7	5	-	-	PUNCT
dpc-2094	7	6	access	access	NOUN
dpc-2094	7	7	article	article	NOUN
dpc-2094	7	8	distributed	distribute	VERB
dpc-2094	7	9	under	under	ADP
dpc-2094	7	10	the	the	DET
dpc-2094	7	11	terms	term	NOUN
dpc-2094	7	12	of	of	ADP
dpc-2094	7	13	the	the	DET
dpc-2094	7	14	creative	creative	ADJ
dpc-2094	7	15	commons	common	NOUN
dpc-2094	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-2094	7	17	license	license	NOUN
dpc-2094	7	18	(	(	PUNCT
dpc-2094	7	19	by	by	ADP
dpc-2094	7	20	-	-	PUNCT
dpc-2094	7	21	nc-4.0	nc-4.0	NOUN
dpc-2094	7	22	)	)	PUNCT
dpc-2094	7	23	,	,	PUNCT
dpc-2094	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2094	7	25	,	,	PUNCT
dpc-2094	7	26	which	which	PRON
dpc-2094	7	27	permits	permit	VERB
dpc-2094	7	28	unrestricted	unrestricted	ADJ
dpc-2094	7	29	noncommercial	noncommercial	ADJ
dpc-2094	7	30	use	use	NOUN
dpc-2094	7	31	,	,	PUNCT
dpc-2094	7	32	distribution	distribution	NOUN
dpc-2094	7	33	,	,	PUNCT
dpc-2094	7	34	and	and	CCONJ
dpc-2094	7	35	reproduction	reproduction	NOUN
dpc-2094	7	36	in	in	ADP
dpc-2094	7	37	any	any	DET
dpc-2094	7	38	medium	medium	NOUN
dpc-2094	7	39	,	,	PUNCT
dpc-2094	7	40	provided	provide	VERB
dpc-2094	7	41	the	the	DET
dpc-2094	7	42	original	original	ADJ
dpc-2094	7	43	authors	author	NOUN
dpc-2094	7	44	and	and	CCONJ
dpc-2094	7	45	source	source	NOUN
dpc-2094	7	46	are	be	AUX
dpc-2094	7	47	credited	credit	VERB
dpc-2094	7	48	.	.	PUNCT
dpc-2094	8	1	funding	funding	NOUN
dpc-2094	8	2	:	:	PUNCT
dpc-2094	8	3	none	none	NOUN
dpc-2094	8	4	.	.	PUNCT
dpc-2094	9	1	competing	compete	VERB
dpc-2094	9	2	interests	interest	NOUN
dpc-2094	9	3	:	:	PUNCT
dpc-2094	9	4	none	none	NOUN
dpc-2094	9	5	.	.	PUNCT
dpc-2094	10	1	authorship	authorship	NOUN
dpc-2094	10	2	:	:	PUNCT
dpc-2094	10	3	all	all	DET
dpc-2094	10	4	authors	author	NOUN
dpc-2094	10	5	have	have	AUX
dpc-2094	10	6	contributed	contribute	VERB
dpc-2094	10	7	significantly	significantly	ADV
dpc-2094	10	8	to	to	ADP
dpc-2094	10	9	this	this	DET
dpc-2094	10	10	publication	publication	NOUN
dpc-2094	10	11	.	.	PUNCT
dpc-2094	11	1	corresponding	correspond	VERB
dpc-2094	11	2	author	author	NOUN
dpc-2094	11	3	:	:	PUNCT
dpc-2094	11	4	francesco	francesco	PROPN
dpc-2094	11	5	messina	messina	PROPN
dpc-2094	11	6	,	,	PUNCT
dpc-2094	11	7	md	md	PROPN
dpc-2094	11	8	,	,	PUNCT
dpc-2094	11	9	dermatology	dermatology	NOUN
dpc-2094	11	10	unit	unit	NOUN
dpc-2094	11	11	,	,	PUNCT
dpc-2094	11	12	department	department	NOUN
dpc-2094	11	13	of	of	ADP
dpc-2094	11	14	medicine	medicine	NOUN
dpc-2094	11	15	,	,	PUNCT
dpc-2094	11	16	university	university	PROPN
dpc-2094	11	17	of	of	ADP
dpc-2094	11	18	padua	padua	PROPN
dpc-2094	11	19	,	,	PUNCT
dpc-2094	11	20	via	via	ADP
dpc-2094	11	21	vincenzo	vincenzo	PROPN
dpc-2094	11	22	gallucci	gallucci	PROPN
dpc-2094	11	23	4	4	NUM
dpc-2094	11	24	,	,	PUNCT
dpc-2094	11	25	35128	35128	NUM
dpc-2094	11	26	padua	padua	PROPN
dpc-2094	11	27	,	,	PUNCT
dpc-2094	11	28	italy	italy	PROPN
dpc-2094	11	29	.	.	PUNCT
dpc-2094	12	1	email	email	NOUN
dpc-2094	12	2	:	:	PUNCT
dpc-2094	12	3	francescomexina@gmail.com	francescomexina@gmail.com	X
dpc-2094	12	4	introduction	introduction	NOUN
dpc-2094	12	5	in	in	ADP
dpc-2094	12	6	this	this	DET
dpc-2094	12	7	report	report	NOUN
dpc-2094	12	8	we	we	PRON
dpc-2094	12	9	describe	describe	VERB
dpc-2094	12	10	the	the	DET
dpc-2094	12	11	occurrence	occurrence	NOUN
dpc-2094	12	12	of	of	ADP
dpc-2094	12	13	a	a	DET
dpc-2094	12	14	primary	primary	ADJ
dpc-2094	12	15	cutaneous	cutaneous	ADJ
dpc-2094	12	16	follicle	follicle	NOUN
dpc-2094	12	17	center	center	NOUN
dpc-2094	12	18	b	b	NOUN
dpc-2094	12	19	lymphoma	lymphoma	NOUN
dpc-2094	12	20	in	in	ADP
dpc-2094	12	21	a	a	DET
dpc-2094	12	22	skin	skin	NOUN
dpc-2094	12	23	area	area	NOUN
dpc-2094	12	24	which	which	PRON
dpc-2094	12	25	had	have	AUX
dpc-2094	12	26	been	be	AUX
dpc-2094	12	27	previously	previously	ADV
dpc-2094	12	28	affected	affect	VERB
dpc-2094	12	29	by	by	ADP
dpc-2094	12	30	a	a	DET
dpc-2094	12	31	herpes	herpe	NOUN
dpc-2094	12	32	zoster	zoster	NOUN
dpc-2094	12	33	eruption	eruption	NOUN
dpc-2094	12	34	.	.	PUNCT
dpc-2094	13	1	the	the	DET
dpc-2094	13	2	rarity	rarity	NOUN
dpc-2094	13	3	of	of	ADP
dpc-2094	13	4	this	this	DET
dpc-2094	13	5	phenomenon	phenomenon	NOUN
dpc-2094	13	6	and	and	CCONJ
dpc-2094	13	7	its	its	PRON
dpc-2094	13	8	complete	complete	ADJ
dpc-2094	13	9	remission	remission	NOUN
dpc-2094	13	10	with	with	ADP
dpc-2094	13	11	topical	topical	ADJ
dpc-2094	13	12	steroid	steroid	NOUN
dpc-2094	13	13	monotherapy	monotherapy	NOUN
dpc-2094	13	14	make	make	VERB
dpc-2094	13	15	this	this	DET
dpc-2094	13	16	report	report	NOUN
dpc-2094	13	17	quite	quite	ADV
dpc-2094	13	18	remarkable	remarkable	ADJ
dpc-2094	13	19	.	.	PUNCT
dpc-2094	14	1	case	case	NOUN
dpc-2094	14	2	presentation	presentation	NOUN
dpc-2094	14	3	we	we	PRON
dpc-2094	14	4	present	present	VERB
dpc-2094	14	5	the	the	DET
dpc-2094	14	6	case	case	NOUN
dpc-2094	14	7	of	of	ADP
dpc-2094	14	8	a	a	DET
dpc-2094	14	9	73	73	NUM
dpc-2094	14	10	-	-	PUNCT
dpc-2094	14	11	year	year	NOUN
dpc-2094	14	12	-	-	PUNCT
dpc-2094	14	13	old	old	ADJ
dpc-2094	14	14	man	man	NOUN
dpc-2094	14	15	who	who	PRON
dpc-2094	14	16	came	come	VERB
dpc-2094	14	17	for	for	ADP
dpc-2094	14	18	the	the	DET
dpc-2094	14	19	first	first	ADJ
dpc-2094	14	20	time	time	NOUN
dpc-2094	14	21	to	to	ADP
dpc-2094	14	22	our	our	PRON
dpc-2094	14	23	dermatology	dermatology	NOUN
dpc-2094	14	24	unit	unit	NOUN
dpc-2094	14	25	in	in	ADP
dpc-2094	14	26	2019	2019	NUM
dpc-2094	14	27	for	for	ADP
dpc-2094	14	28	a	a	DET
dpc-2094	14	29	burning	burning	NOUN
dpc-2094	14	30	and	and	CCONJ
dpc-2094	14	31	stinging	sting	VERB
dpc-2094	14	32	blistering	blister	VERB
dpc-2094	14	33	eruption	eruption	NOUN
dpc-2094	14	34	on	on	ADP
dpc-2094	14	35	the	the	DET
dpc-2094	14	36	left	left	ADJ
dpc-2094	14	37	scapular	scapular	ADJ
dpc-2094	14	38	area	area	NOUN
dpc-2094	14	39	with	with	ADP
dpc-2094	14	40	a	a	DET
dpc-2094	14	41	metameric	metameric	ADJ
dpc-2094	14	42	distribution	distribution	NOUN
dpc-2094	14	43	,	,	PUNCT
dpc-2094	14	44	highly	highly	ADV
dpc-2094	14	45	indicative	indicative	ADJ
dpc-2094	14	46	for	for	ADP
dpc-2094	14	47	a	a	DET
dpc-2094	14	48	herpes	herpe	NOUN
dpc-2094	14	49	zoster	zoster	NOUN
dpc-2094	14	50	outbreak	outbreak	NOUN
dpc-2094	14	51	.	.	PUNCT
dpc-2094	15	1	we	we	PRON
dpc-2094	15	2	treated	treat	VERB
dpc-2094	15	3	him	he	PRON
dpc-2094	15	4	with	with	ADP
dpc-2094	15	5	acyclovir	acyclovir	PROPN
dpc-2094	15	6	800	800	NUM
dpc-2094	15	7	mg	mg	PROPN
dpc-2094	15	8	five	five	NUM
dpc-2094	15	9	times	time	NOUN
dpc-2094	15	10	daily	daily	ADV
dpc-2094	15	11	for	for	ADP
dpc-2094	15	12	seven	seven	NUM
dpc-2094	15	13	days	day	NOUN
dpc-2094	15	14	with	with	ADP
dpc-2094	15	15	a	a	DET
dpc-2094	15	16	complete	complete	ADJ
dpc-2094	15	17	resolution	resolution	NOUN
dpc-2094	15	18	of	of	ADP
dpc-2094	15	19	lesions	lesion	NOUN
dpc-2094	15	20	.	.	PUNCT
dpc-2094	16	1	after	after	ADP
dpc-2094	16	2	seven	seven	NUM
dpc-2094	16	3	months	month	NOUN
dpc-2094	16	4	the	the	DET
dpc-2094	16	5	patient	patient	NOUN
dpc-2094	16	6	returned	return	VERB
dpc-2094	16	7	complaining	complain	VERB
dpc-2094	16	8	about	about	ADP
dpc-2094	16	9	the	the	DET
dpc-2094	16	10	development	development	NOUN
dpc-2094	16	11	of	of	ADP
dpc-2094	16	12	six	six	NUM
dpc-2094	16	13	infiltrated	infiltrate	VERB
dpc-2094	16	14	plaques	plaque	NOUN
dpc-2094	16	15	on	on	ADP
dpc-2094	16	16	the	the	DET
dpc-2094	16	17	left	left	ADJ
dpc-2094	16	18	scapular	scapular	ADJ
dpc-2094	16	19	region	region	NOUN
dpc-2094	16	20	,	,	PUNCT
dpc-2094	16	21	whose	whose	DET
dpc-2094	16	22	distribution	distribution	NOUN
dpc-2094	16	23	was	be	AUX
dpc-2094	16	24	perfectly	perfectly	ADV
dpc-2094	16	25	overlapping	overlap	VERB
dpc-2094	16	26	with	with	ADP
dpc-2094	16	27	the	the	DET
dpc-2094	16	28	resolved	resolve	VERB
dpc-2094	16	29	shingles	shingle	NOUN
dpc-2094	16	30	eruption	eruption	NOUN
dpc-2094	16	31	(	(	PUNCT
dpc-2094	16	32	figure	figure	NOUN
dpc-2094	16	33	1a	1a	NOUN
dpc-2094	16	34	)	)	PUNCT
dpc-2094	16	35	.	.	PUNCT
dpc-2094	17	1	a	a	DET
dpc-2094	17	2	biopsy	biopsy	NOUN
dpc-2094	17	3	was	be	AUX
dpc-2094	17	4	performed	perform	VERB
dpc-2094	17	5	,	,	PUNCT
dpc-2094	17	6	and	and	CCONJ
dpc-2094	17	7	the	the	DET
dpc-2094	17	8	histologic	histologic	ADJ
dpc-2094	17	9	specimen	speciman	NOUN
dpc-2094	17	10	showed	show	VERB
dpc-2094	17	11	a	a	DET
dpc-2094	17	12	proliferation	proliferation	NOUN
dpc-2094	17	13	of	of	ADP
dpc-2094	17	14	neoplastic	neoplastic	ADJ
dpc-2094	17	15	follicle	follicle	NOUN
dpc-2094	17	16	center	center	NOUN
dpc-2094	17	17	cells	cell	NOUN
dpc-2094	17	18	invading	invade	VERB
dpc-2094	17	19	the	the	DET
dpc-2094	17	20	entire	entire	ADJ
dpc-2094	17	21	dermis	dermis	NOUN
dpc-2094	17	22	(	(	PUNCT
dpc-2094	17	23	figure	figure	NOUN
dpc-2094	17	24	2	2	NUM
dpc-2094	17	25	)	)	PUNCT
dpc-2094	17	26	.	.	PUNCT
dpc-2094	18	1	epidermis	epidermis	PROPN
dpc-2094	18	2	was	be	AUX
dpc-2094	18	3	spared	spare	VERB
dpc-2094	18	4	and	and	CCONJ
dpc-2094	18	5	separated	separate	VERB
dpc-2094	18	6	from	from	ADP
dpc-2094	18	7	the	the	DET
dpc-2094	18	8	proliferating	proliferate	VERB
dpc-2094	18	9	lymphocytes	lymphocyte	NOUN
dpc-2094	18	10	by	by	ADP
dpc-2094	18	11	a	a	DET
dpc-2094	18	12	grenz	grenz	NOUN
dpc-2094	18	13	zone	zone	NOUN
dpc-2094	18	14	in	in	ADP
dpc-2094	18	15	the	the	DET
dpc-2094	18	16	upper	upper	ADJ
dpc-2094	18	17	dermis	dermis	NOUN
dpc-2094	18	18	.	.	PUNCT
dpc-2094	19	1	b	b	X
dpc-2094	19	2	-	-	PUNCT
dpc-2094	19	3	cell	cell	NOUN
dpc-2094	19	4	immunohistochemistry	immunohistochemistry	NOUN
dpc-2094	19	5	was	be	AUX
dpc-2094	19	6	positive	positive	ADJ
dpc-2094	19	7	for	for	ADP
dpc-2094	19	8	cd20	cd20	PROPN
dpc-2094	19	9	and	and	CCONJ
dpc-2094	19	10	bcl6	bcl6	PROPN
dpc-2094	19	11	and	and	CCONJ
dpc-2094	19	12	only	only	ADV
dpc-2094	19	13	weakly	weakly	ADV
dpc-2094	19	14	positive	positive	ADJ
dpc-2094	19	15	for	for	ADP
dpc-2094	19	16	bcl2	bcl2	NOUN
dpc-2094	19	17	.	.	PUNCT
dpc-2094	20	1	furthermore	furthermore	ADV
dpc-2094	20	2	,	,	PUNCT
dpc-2094	20	3	pcr	pcr	PROPN
dpc-2094	20	4	demonstrated	demonstrate	VERB
dpc-2094	20	5	monoclonal	monoclonal	NOUN
dpc-2094	20	6	immunoglobulin	immunoglobulin	NOUN
dpc-2094	20	7	heavy	heavy	ADJ
dpc-2094	20	8	chain	chain	NOUN
dpc-2094	20	9	gene	gene	NOUN
dpc-2094	20	10	rearrangement	rearrangement	NOUN
dpc-2094	20	11	.	.	PUNCT
dpc-2094	21	1	thus	thus	ADV
dpc-2094	21	2	,	,	PUNCT
dpc-2094	21	3	a	a	DET
dpc-2094	21	4	diagnosis	diagnosis	NOUN
dpc-2094	21	5	of	of	ADP
dpc-2094	21	6	cutaneous	cutaneous	ADJ
dpc-2094	21	7	follicle	follicle	NOUN
dpc-2094	21	8	center	center	NOUN
dpc-2094	21	9	lymphoma	lymphoma	NOUN
dpc-2094	21	10	was	be	AUX
dpc-2094	21	11	made	make	VERB
dpc-2094	21	12	.	.	PUNCT
dpc-2094	22	1	the	the	DET
dpc-2094	22	2	patient	patient	NOUN
dpc-2094	22	3	had	have	VERB
dpc-2094	22	4	no	no	DET
dpc-2094	22	5	medical	medical	ADJ
dpc-2094	22	6	history	history	NOUN
dpc-2094	22	7	of	of	ADP
dpc-2094	22	8	malignancy	malignancy	NOUN
dpc-2094	22	9	,	,	PUNCT
dpc-2094	22	10	and	and	CCONJ
dpc-2094	22	11	his	his	PRON
dpc-2094	22	12	only	only	ADJ
dpc-2094	22	13	comorbidity	comorbidity	NOUN
dpc-2094	22	14	was	be	AUX
dpc-2094	22	15	hypertension	hypertension	NOUN
dpc-2094	22	16	.	.	PUNCT
dpc-2094	23	1	a	a	DET
dpc-2094	23	2	pet	pet	NOUN
dpc-2094	23	3	-	-	PUNCT
dpc-2094	23	4	tc	tc	NOUN
dpc-2094	23	5	was	be	AUX
dpc-2094	23	6	performed	perform	VERB
dpc-2094	23	7	to	to	PART
dpc-2094	23	8	complete	complete	VERB
dpc-2094	23	9	the	the	DET
dpc-2094	23	10	staging	staging	NOUN
dpc-2094	23	11	and	and	CCONJ
dpc-2094	23	12	it	it	PRON
dpc-2094	23	13	resulted	result	VERB
dpc-2094	23	14	negative	negative	ADJ
dpc-2094	23	15	.	.	PUNCT
dpc-2094	24	1	this	this	DET
dpc-2094	24	2	outcome	outcome	NOUN
dpc-2094	24	3	justified	justify	VERB
dpc-2094	24	4	a	a	DET
dpc-2094	24	5	conservative	conservative	ADJ
dpc-2094	24	6	approach	approach	NOUN
dpc-2094	24	7	,	,	PUNCT
dpc-2094	24	8	therefore	therefore	ADV
dpc-2094	24	9	we	we	PRON
dpc-2094	24	10	prescribed	prescribe	VERB
dpc-2094	24	11	clobetasol	clobetasol	NOUN
dpc-2094	24	12	propionate	propionate	NOUN
dpc-2094	24	13	topical	topical	ADJ
dpc-2094	24	14	ointment	ointment	NOUN
dpc-2094	24	15	0.05	0.05	NUM
dpc-2094	24	16	%	%	NOUN
dpc-2094	24	17	one	one	NUM
dpc-2094	24	18	application	application	NOUN
dpc-2094	24	19	per	per	ADP
dpc-2094	24	20	day	day	NOUN
dpc-2094	24	21	to	to	PART
dpc-2094	24	22	treat	treat	VERB
dpc-2094	24	23	the	the	DET
dpc-2094	24	24	skin	skin	NOUN
dpc-2094	24	25	lesions	lesion	NOUN
dpc-2094	24	26	.	.	PUNCT
dpc-2094	25	1	after	after	ADP
dpc-2094	25	2	6	6	NUM
dpc-2094	25	3	weeks	week	NOUN
dpc-2094	25	4	,	,	PUNCT
dpc-2094	25	5	all	all	DET
dpc-2094	25	6	lesions	lesion	NOUN
dpc-2094	25	7	were	be	AUX
dpc-2094	25	8	already	already	ADV
dpc-2094	25	9	in	in	ADP
dpc-2094	25	10	complete	complete	ADJ
dpc-2094	25	11	remission	remission	NOUN
dpc-2094	25	12	(	(	PUNCT
dpc-2094	25	13	figure	figure	NOUN
dpc-2094	25	14	1b	1b	NUM
dpc-2094	25	15	)	)	PUNCT
dpc-2094	25	16	.	.	PUNCT
dpc-2094	26	1	2	2	NUM
dpc-2094	26	2	research	research	NOUN
dpc-2094	26	3	letter	letter	NOUN
dpc-2094	26	4	|	|	ADV
dpc-2094	26	5	dermatol	dermatol	ADJ
dpc-2094	26	6	pract	pract	NOUN
dpc-2094	26	7	concept	concept	NOUN
dpc-2094	26	8	.	.	PUNCT
dpc-2094	27	1	2022;12(4):e2022169	2022;12(4):e2022169	PROPN
dpc-2094	27	2	conclusions	conclusion	VERB
dpc-2094	27	3	the	the	DET
dpc-2094	27	4	occurrence	occurrence	NOUN
dpc-2094	27	5	of	of	ADP
dpc-2094	27	6	a	a	DET
dpc-2094	27	7	skin	skin	NOUN
dpc-2094	27	8	disease	disease	NOUN
dpc-2094	27	9	in	in	ADP
dpc-2094	27	10	an	an	DET
dpc-2094	27	11	area	area	NOUN
dpc-2094	27	12	which	which	PRON
dpc-2094	27	13	had	have	AUX
dpc-2094	27	14	previously	previously	ADV
dpc-2094	27	15	been	be	AUX
dpc-2094	27	16	affected	affect	VERB
dpc-2094	27	17	by	by	ADP
dpc-2094	27	18	another	another	DET
dpc-2094	27	19	unrelated	unrelated	ADJ
dpc-2094	27	20	dermatosis	dermatosis	NOUN
dpc-2094	27	21	is	be	AUX
dpc-2094	27	22	known	know	VERB
dpc-2094	27	23	as	as	ADP
dpc-2094	27	24	wolf	wolf	PROPN
dpc-2094	27	25	isotopic	isotopic	ADJ
dpc-2094	27	26	response	response	NOUN
dpc-2094	27	27	.	.	PUNCT
dpc-2094	28	1	this	this	DET
dpc-2094	28	2	phenomenon	phenomenon	NOUN
dpc-2094	28	3	often	often	ADV
dpc-2094	28	4	occurs	occur	VERB
dpc-2094	28	5	with	with	ADP
dpc-2094	28	6	vzv	vzv	PROPN
dpc-2094	28	7	infection	infection	NOUN
dpc-2094	28	8	representing	represent	VERB
dpc-2094	28	9	the	the	DET
dpc-2094	28	10	“	"	PUNCT
dpc-2094	28	11	first	first	ADJ
dpc-2094	28	12	hit	hit	NOUN
dpc-2094	28	13	”	"	PUNCT
dpc-2094	28	14	[	[	X
dpc-2094	28	15	1	1	NUM
dpc-2094	28	16	]	]	PUNCT
dpc-2094	28	17	.	.	PUNCT
dpc-2094	29	1	the	the	DET
dpc-2094	29	2	second	second	ADJ
dpc-2094	29	3	dermatosis	dermatosis	NOUN
dpc-2094	29	4	is	be	AUX
dpc-2094	29	5	usually	usually	ADV
dpc-2094	29	6	a	a	DET
dpc-2094	29	7	granulomatous	granulomatous	ADJ
dpc-2094	29	8	or	or	CCONJ
dpc-2094	29	9	lichenoid	lichenoid	PROPN
dpc-2094	29	10	manifestation	manifestation	NOUN
dpc-2094	29	11	,	,	PUNCT
dpc-2094	29	12	however	however	SCONJ
dpc-2094	29	13	infiltrations	infiltration	NOUN
dpc-2094	29	14	by	by	ADP
dpc-2094	29	15	hematologic	hematologic	ADJ
dpc-2094	29	16	malignancies	malignancy	NOUN
dpc-2094	29	17	,	,	PUNCT
dpc-2094	29	18	skin	skin	NOUN
dpc-2094	29	19	tumors	tumor	NOUN
dpc-2094	29	20	,	,	PUNCT
dpc-2094	29	21	and	and	CCONJ
dpc-2094	29	22	infections	infection	NOUN
dpc-2094	29	23	have	have	AUX
dpc-2094	29	24	been	be	AUX
dpc-2094	29	25	described	describe	VERB
dpc-2094	29	26	as	as	ADP
dpc-2094	29	27	well	well	ADV
dpc-2094	29	28	[	[	X
dpc-2094	29	29	1	1	NUM
dpc-2094	29	30	]	]	PUNCT
dpc-2094	29	31	.	.	PUNCT
dpc-2094	30	1	although	although	SCONJ
dpc-2094	30	2	unfrequently	unfrequently	ADV
dpc-2094	30	3	,	,	PUNCT
dpc-2094	30	4	also	also	ADV
dpc-2094	30	5	pseudo	pseudo	NOUN
dpc-2094	30	6	-	-	ADJ
dpc-2094	30	7	lymphomatous	lymphomatous	ADJ
dpc-2094	30	8	infiltrates	infiltrate	NOUN
dpc-2094	30	9	have	have	AUX
dpc-2094	30	10	been	be	AUX
dpc-2094	30	11	observed	observe	VERB
dpc-2094	30	12	in	in	ADP
dpc-2094	30	13	the	the	DET
dpc-2094	30	14	area	area	NOUN
dpc-2094	30	15	of	of	ADP
dpc-2094	30	16	a	a	DET
dpc-2094	30	17	former	former	ADJ
dpc-2094	30	18	herpes	herpe	NOUN
dpc-2094	30	19	zoster	zoster	NOUN
dpc-2094	30	20	[	[	X
dpc-2094	30	21	1	1	NUM
dpc-2094	30	22	]	]	PUNCT
dpc-2094	30	23	,	,	PUNCT
dpc-2094	30	24	while	while	SCONJ
dpc-2094	30	25	the	the	DET
dpc-2094	30	26	onset	onset	NOUN
dpc-2094	30	27	of	of	ADP
dpc-2094	30	28	primary	primary	ADJ
dpc-2094	30	29	cutaneous	cutaneous	ADJ
dpc-2094	30	30	lymphomas	lymphoma	NOUN
dpc-2094	30	31	in	in	ADP
dpc-2094	30	32	this	this	DET
dpc-2094	30	33	setting	setting	NOUN
dpc-2094	30	34	is	be	AUX
dpc-2094	30	35	only	only	ADV
dpc-2094	30	36	anecdotal	anecdotal	ADJ
dpc-2094	30	37	[	[	X
dpc-2094	30	38	2	2	NUM
dpc-2094	30	39	]	]	PUNCT
dpc-2094	30	40	.	.	PUNCT
dpc-2094	31	1	in	in	ADP
dpc-2094	31	2	order	order	NOUN
dpc-2094	31	3	to	to	PART
dpc-2094	31	4	explain	explain	VERB
dpc-2094	31	5	this	this	DET
dpc-2094	31	6	phenomenon	phenomenon	NOUN
dpc-2094	31	7	,	,	PUNCT
dpc-2094	31	8	it	it	PRON
dpc-2094	31	9	has	have	AUX
dpc-2094	31	10	been	be	AUX
dpc-2094	31	11	suggested	suggest	VERB
dpc-2094	31	12	that	that	SCONJ
dpc-2094	31	13	varicella	varicella	NOUN
dpc-2094	31	14	-	-	PUNCT
dpc-2094	31	15	zoster	zoster	NOUN
dpc-2094	31	16	virus	virus	NOUN
dpc-2094	31	17	(	(	PUNCT
dpc-2094	31	18	vzv	vzv	PROPN
dpc-2094	31	19	)	)	PUNCT
dpc-2094	31	20	infection	infection	NOUN
dpc-2094	31	21	might	might	AUX
dpc-2094	31	22	cause	cause	VERB
dpc-2094	31	23	an	an	DET
dpc-2094	31	24	abnormal	abnormal	ADJ
dpc-2094	31	25	lymphocytic	lymphocytic	ADJ
dpc-2094	31	26	activation	activation	NOUN
dpc-2094	31	27	;	;	PUNCT
dpc-2094	31	28	however	however	ADV
dpc-2094	31	29	,	,	PUNCT
dpc-2094	31	30	only	only	ADV
dpc-2094	31	31	in	in	ADP
dpc-2094	31	32	isolated	isolated	ADJ
dpc-2094	31	33	cases	case	NOUN
dpc-2094	31	34	vzv	vzv	PROPN
dpc-2094	31	35	dna	dna	PROPN
dpc-2094	31	36	was	be	AUX
dpc-2094	31	37	found	find	VERB
dpc-2094	31	38	in	in	ADP
dpc-2094	31	39	the	the	DET
dpc-2094	31	40	histologic	histologic	ADJ
dpc-2094	31	41	specimen	speciman	NOUN
dpc-2094	31	42	[	[	X
dpc-2094	31	43	1,2	1,2	NUM
dpc-2094	31	44	]	]	PUNCT
dpc-2094	31	45	.	.	PUNCT
dpc-2094	32	1	an	an	DET
dpc-2094	32	2	additional	additional	ADJ
dpc-2094	32	3	explanation	explanation	NOUN
dpc-2094	32	4	might	might	AUX
dpc-2094	32	5	be	be	AUX
dpc-2094	32	6	that	that	SCONJ
dpc-2094	32	7	vzv	vzv	PROPN
dpc-2094	32	8	infection	infection	NOUN
dpc-2094	32	9	locally	locally	ADV
dpc-2094	32	10	reduces	reduce	VERB
dpc-2094	32	11	the	the	DET
dpc-2094	32	12	immune	immune	ADJ
dpc-2094	32	13	surveillance	surveillance	NOUN
dpc-2094	32	14	,	,	PUNCT
dpc-2094	32	15	thereby	thereby	ADV
dpc-2094	32	16	facilitating	facilitate	VERB
dpc-2094	32	17	the	the	DET
dpc-2094	32	18	onset	onset	NOUN
dpc-2094	32	19	of	of	ADP
dpc-2094	32	20	neoplasms	neoplasm	NOUN
dpc-2094	32	21	in	in	ADP
dpc-2094	32	22	the	the	DET
dpc-2094	32	23	affected	affected	ADJ
dpc-2094	32	24	area	area	NOUN
dpc-2094	32	25	[	[	X
dpc-2094	32	26	1	1	NUM
dpc-2094	32	27	]	]	PUNCT
dpc-2094	32	28	.	.	PUNCT
dpc-2094	33	1	in	in	ADP
dpc-2094	33	2	this	this	DET
dpc-2094	33	3	report	report	NOUN
dpc-2094	33	4	we	we	PRON
dpc-2094	33	5	have	have	AUX
dpc-2094	33	6	described	describe	VERB
dpc-2094	33	7	the	the	DET
dpc-2094	33	8	appearance	appearance	NOUN
dpc-2094	33	9	of	of	ADP
dpc-2094	33	10	a	a	DET
dpc-2094	33	11	primary	primary	ADJ
dpc-2094	33	12	cutaneous	cutaneous	ADJ
dpc-2094	33	13	follicular	follicular	ADJ
dpc-2094	33	14	b	b	NOUN
dpc-2094	33	15	-	-	PUNCT
dpc-2094	33	16	cell	cell	NOUN
dpc-2094	33	17	lymphoma	lymphoma	NOUN
dpc-2094	33	18	in	in	ADP
dpc-2094	33	19	the	the	DET
dpc-2094	33	20	same	same	ADJ
dpc-2094	33	21	area	area	NOUN
dpc-2094	33	22	where	where	SCONJ
dpc-2094	33	23	a	a	DET
dpc-2094	33	24	shingles	shingle	NOUN
dpc-2094	33	25	outbreak	outbreak	NOUN
dpc-2094	33	26	had	have	AUX
dpc-2094	33	27	occurred	occur	VERB
dpc-2094	33	28	7	7	NUM
dpc-2094	33	29	months	month	NOUN
dpc-2094	33	30	before	before	ADV
dpc-2094	33	31	.	.	PUNCT
dpc-2094	34	1	one	one	NUM
dpc-2094	34	2	similar	similar	ADJ
dpc-2094	34	3	case	case	NOUN
dpc-2094	34	4	already	already	ADV
dpc-2094	34	5	described	describe	VERB
dpc-2094	34	6	in	in	ADP
dpc-2094	34	7	literature	literature	NOUN
dpc-2094	34	8	regarded	regard	VERB
dpc-2094	34	9	a	a	DET
dpc-2094	34	10	centrocytic	centrocytic	ADJ
dpc-2094	34	11	/	/	SYM
dpc-2094	34	12	centroblastic	centroblastic	ADJ
dpc-2094	34	13	lymphoma	lymphoma	NOUN
dpc-2094	34	14	which	which	PRON
dpc-2094	34	15	was	be	AUX
dpc-2094	34	16	treated	treat	VERB
dpc-2094	34	17	with	with	ADP
dpc-2094	34	18	systemic	systemic	ADJ
dpc-2094	34	19	interferon	interferon	ADJ
dpc-2094	34	20	alpha	alpha	NOUN
dpc-2094	34	21	obtaining	obtain	VERB
dpc-2094	34	22	only	only	ADJ
dpc-2094	34	23	partial	partial	ADJ
dpc-2094	34	24	remission	remission	NOUN
dpc-2094	34	25	[	[	X
dpc-2094	34	26	2	2	NUM
dpc-2094	34	27	]	]	PUNCT
dpc-2094	34	28	.	.	PUNCT
dpc-2094	35	1	in	in	ADP
dpc-2094	35	2	contrast	contrast	NOUN
dpc-2094	35	3	,	,	PUNCT
dpc-2094	35	4	our	our	PRON
dpc-2094	35	5	case	case	NOUN
dpc-2094	35	6	went	go	VERB
dpc-2094	35	7	into	into	ADP
dpc-2094	35	8	stable	stable	ADJ
dpc-2094	35	9	remission	remission	NOUN
dpc-2094	35	10	after	after	ADP
dpc-2094	35	11	application	application	NOUN
dpc-2094	35	12	of	of	ADP
dpc-2094	35	13	topical	topical	ADJ
dpc-2094	35	14	steroids	steroid	NOUN
dpc-2094	35	15	alone	alone	ADJ
dpc-2094	35	16	and	and	CCONJ
dpc-2094	35	17	to	to	ADP
dpc-2094	35	18	date	date	NOUN
dpc-2094	35	19	no	no	DET
dpc-2094	35	20	recurrence	recurrence	NOUN
dpc-2094	35	21	was	be	AUX
dpc-2094	35	22	observed	observe	VERB
dpc-2094	35	23	after	after	ADP
dpc-2094	35	24	14	14	NUM
dpc-2094	35	25	months	month	NOUN
dpc-2094	35	26	of	of	ADP
dpc-2094	35	27	follow	follow	NOUN
dpc-2094	35	28	-	-	PUNCT
dpc-2094	35	29	up	up	NOUN
dpc-2094	35	30	,	,	PUNCT
dpc-2094	35	31	suggesting	suggest	VERB
dpc-2094	35	32	that	that	SCONJ
dpc-2094	35	33	clobetasol	clobetasol	NOUN
dpc-2094	35	34	monotherapy	monotherapy	NOUN
dpc-2094	35	35	might	might	AUX
dpc-2094	35	36	represent	represent	VERB
dpc-2094	35	37	a	a	DET
dpc-2094	35	38	valid	valid	ADJ
dpc-2094	35	39	treatment	treatment	NOUN
dpc-2094	35	40	option	option	NOUN
dpc-2094	35	41	for	for	ADP
dpc-2094	35	42	this	this	DET
dpc-2094	35	43	kind	kind	NOUN
dpc-2094	35	44	of	of	ADP
dpc-2094	35	45	cutaneous	cutaneous	ADJ
dpc-2094	35	46	neoplasm	neoplasm	NOUN
dpc-2094	35	47	.	.	PUNCT
dpc-2094	36	1	references	reference	NOUN
dpc-2094	36	2	1	1	NUM
dpc-2094	36	3	.	.	PUNCT
dpc-2094	36	4	jaka	jaka	PROPN
dpc-2094	36	5	-	-	PUNCT
dpc-2094	36	6	moreno	moreno	PROPN
dpc-2094	36	7	a	a	PROPN
dpc-2094	36	8	,	,	PUNCT
dpc-2094	36	9	lópez	lópez	NOUN
dpc-2094	36	10	-	-	PUNCT
dpc-2094	36	11	pestaña	pestaña	PROPN
dpc-2094	36	12	a	a	PRON
dpc-2094	36	13	,	,	PUNCT
dpc-2094	36	14	lópez	lópez	PROPN
dpc-2094	36	15	-	-	PUNCT
dpc-2094	36	16	núñez	núñez	PROPN
dpc-2094	36	17	m	m	PROPN
dpc-2094	36	18	,	,	PUNCT
dpc-2094	36	19	et	et	PROPN
dpc-2094	36	20	al	al	PROPN
dpc-2094	36	21	.	.	PROPN
dpc-2094	36	22	wolf	wolf	PROPN
dpc-2094	36	23	’s	’s	PART
dpc-2094	36	24	isotopic	isotopic	ADJ
dpc-2094	36	25	response	response	NOUN
dpc-2094	36	26	:	:	PUNCT
dpc-2094	36	27	a	a	DET
dpc-2094	36	28	series	series	NOUN
dpc-2094	36	29	of	of	ADP
dpc-2094	36	30	9	9	NUM
dpc-2094	36	31	cases	case	NOUN
dpc-2094	36	32	.	.	PUNCT
dpc-2094	37	1	actas	actas	NOUN
dpc-2094	37	2	dermosifiliogr	dermosifiliogr	NOUN
dpc-2094	37	3	.	.	PUNCT
dpc-2094	38	1	2012;103(9):798–805	2012;103(9):798–805	NUM
dpc-2094	38	2	.	.	PUNCT
dpc-2094	39	1	doi	doi	NOUN
dpc-2094	39	2	:	:	PUNCT
dpc-2094	39	3	10.1016	10.1016	NUM
dpc-2094	39	4	/	/	SYM
dpc-2094	39	5	j.ad.2012.02.007	j.ad.2012.02.007	PROPN
dpc-2094	39	6	.	.	PUNCT
dpc-2094	40	1	pmid	pmid	NOUN
dpc-2094	40	2	:	:	PUNCT
dpc-2094	40	3	22681715	22681715	NUM
dpc-2094	40	4	.	.	PUNCT
dpc-2094	41	1	2	2	X
dpc-2094	41	2	.	.	X
dpc-2094	41	3	drago	drago	PROPN
dpc-2094	41	4	f	f	PROPN
dpc-2094	41	5	,	,	PUNCT
dpc-2094	41	6	rampini	rampini	PROPN
dpc-2094	41	7	p	p	PROPN
dpc-2094	41	8	,	,	PUNCT
dpc-2094	41	9	lugani	lugani	PROPN
dpc-2094	41	10	c	c	NOUN
dpc-2094	41	11	,	,	PUNCT
dpc-2094	41	12	rebora	rebora	PROPN
dpc-2094	41	13	a.	a.	PROPN
dpc-2094	41	14	centroblastic	centroblastic	PROPN
dpc-2094	41	15	centrocytic	centrocytic	ADJ
dpc-2094	41	16	lymphoma	lymphoma	NOUN
dpc-2094	41	17	arising	arise	VERB
dpc-2094	41	18	at	at	ADP
dpc-2094	41	19	the	the	DET
dpc-2094	41	20	site	site	NOUN
dpc-2094	41	21	of	of	ADP
dpc-2094	41	22	previous	previous	ADJ
dpc-2094	41	23	herpes	herpe	NOUN
dpc-2094	41	24	zoster	zoster	NOUN
dpc-2094	41	25	eruption	eruption	NOUN
dpc-2094	41	26	.	.	PUNCT
dpc-2094	42	1	acta	acta	PROPN
dpc-2094	42	2	derm	derm	PROPN
dpc-2094	42	3	venereol	venereol	NOUN
dpc-2094	42	4	.	.	PUNCT
dpc-2094	43	1	1998;78(1):74–75	1998;78(1):74–75	X
dpc-2094	43	2	.	.	PUNCT
dpc-2094	43	3	doi	doi	NOUN
dpc-2094	43	4	:	:	PUNCT
dpc-2094	43	5	10.1080/00015559850135959	10.1080/00015559850135959	NUM
dpc-2094	43	6	.	.	PUNCT
dpc-2094	44	1	pmid	pmid	NOUN
dpc-2094	44	2	:	:	PUNCT
dpc-2094	44	3	9498039	9498039	NUM
dpc-2094	44	4	.	.	PUNCT
dpc-2094	45	1	figure	figure	NOUN
dpc-2094	45	2	1	1	NUM
dpc-2094	45	3	.	.	PUNCT
dpc-2094	46	1	(	(	PUNCT
dpc-2094	46	2	a	a	X
dpc-2094	46	3	)	)	PUNCT
dpc-2094	46	4	clinical	clinical	ADJ
dpc-2094	46	5	appearance	appearance	NOUN
dpc-2094	46	6	of	of	ADP
dpc-2094	46	7	lymphomatous	lymphomatous	ADJ
dpc-2094	46	8	plaques	plaque	NOUN
dpc-2094	46	9	on	on	ADP
dpc-2094	46	10	the	the	DET
dpc-2094	46	11	patient	patient	NOUN
dpc-2094	46	12	left	leave	VERB
dpc-2094	46	13	scapular	scapular	ADJ
dpc-2094	46	14	region	region	NOUN
dpc-2094	46	15	.	.	PUNCT
dpc-2094	47	1	(	(	PUNCT
dpc-2094	47	2	b	b	X
dpc-2094	47	3	)	)	PUNCT
dpc-2094	47	4	complete	complete	ADJ
dpc-2094	47	5	resolution	resolution	NOUN
dpc-2094	47	6	of	of	ADP
dpc-2094	47	7	lesions	lesion	NOUN
dpc-2094	47	8	after	after	ADP
dpc-2094	47	9	topical	topical	ADJ
dpc-2094	47	10	steroid	steroid	NOUN
dpc-2094	47	11	application	application	NOUN
dpc-2094	47	12	.	.	PUNCT
dpc-2094	48	1	figure	figure	NOUN
dpc-2094	48	2	2	2	NUM
dpc-2094	48	3	.	.	PUNCT
dpc-2094	48	4	bioptic	bioptic	ADJ
dpc-2094	48	5	specimen	speciman	NOUN
dpc-2094	48	6	of	of	ADP
dpc-2094	48	7	one	one	NUM
dpc-2094	48	8	of	of	ADP
dpc-2094	48	9	the	the	DET
dpc-2094	48	10	lesions	lesion	NOUN
dpc-2094	48	11	.	.	PUNCT
dpc-2094	49	1	a	a	DET
dpc-2094	49	2	neoplastic	neoplastic	ADJ
dpc-2094	49	3	infiltration	infiltration	NOUN
dpc-2094	49	4	of	of	ADP
dpc-2094	49	5	atypical	atypical	ADJ
dpc-2094	49	6	lymphocytes	lymphocyte	NOUN
dpc-2094	49	7	is	be	AUX
dpc-2094	49	8	observed	observe	VERB
dpc-2094	49	9	in	in	ADP
dpc-2094	49	10	the	the	DET
dpc-2094	49	11	dermis	dermis	NOUN
dpc-2094	49	12	(	(	PUNCT
dpc-2094	49	13	h&e	h&e	PROPN
dpc-2094	49	14	x20	x20	PROPN
dpc-2094	49	15	)	)	PUNCT
dpc-2094	49	16	.	.	PUNCT